首页 > 最新文献

Pediatric Blood & Cancer最新文献

英文 中文
Clinical practice guideline-inconsistent chemotherapy-induced vomiting prophylaxis in pediatric cancer patients in community settings: A Children's Oncology Group study 社区儿童癌症患者化疗引起的呕吐预防措施与临床实践指南不一致:儿童肿瘤学小组的一项研究。
IF 2.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2024-09-05 DOI: 10.1002/pbc.31295
Aaron J. Sugalski, Allison C. Grimes, Michelle M. Nuño, Subhash Ramakrishnan, Melissa P. Beauchemin, Paula D. Robinson, Nancy Santesso, Alexandra M. Walsh, Andrea R. Wrightson, Lolie C. Yu, Susan K. Parsons, Lillian Sung, L. Lee Dupuis

Background

This study aimed to determine the proportion of patients receiving clinical practice guideline (CPG)-inconsistent care related to chemotherapy-induced vomiting (CIV) prophylaxis, and to describe the association between CPG-inconsistent care and site size. The association between delivery of CPG-inconsistent care and patient outcomes (CIV control, admission prolongation, and unplanned healthcare visits) was also described.

Methods

This was a retrospective study conducted at Children's Oncology Group (COG) National Cancer Institute Community Oncology Research Program (NCORP) sites. Eligible patients received highly (HEC) or moderately emetogenic chemotherapy (MEC) as inpatients from January 2014 through December 2015, and were previously enrolled in a COG study. The COG generated a patient list from which patients were randomly selected for chart review by participating sites. A central panel adjudicated CIV prophylaxis received as CPG-consistent or -inconsistent.

Results

Twenty-four sites participated. Over half of patients received CPG-inconsistent CIV prophylaxis (HEC: 59/112, 52.6%; MEC: 119/215, 55.3%). The most common reasons for CPG-inconsistency were shortened duration of antiemetic administration or omission of dexamethasone. Site size was not found to be associated with CPG-inconsistent care delivery (HEC: adjusted odds ratio [OR]: 0.96, 95% confidence interval [CI]: 0.76–1.23; MEC: adjusted OR: 1.07; 95% CI: 0.92–1.24). Additionally, there was no statistically significant association between receipt of CPG-inconsistent care and patient outcomes.

Conclusions

Patients receiving MEC or HEC often received CPG-inconsistent CIV prophylaxis. Site size was not associated with receipt of CPG-inconsistent care. Future studies should evaluate strategies to improve CIV control among pediatric oncology patients including those aimed at improving CPG adherence.

研究背景本研究旨在确定接受与化疗引起的呕吐(CIV)预防相关的临床实践指南(CPG)不一致护理的患者比例,并描述CPG不一致护理与医院规模之间的关联。此外,还描述了与 CPG 不一致的护理服务与患者预后(CIV 控制、入院时间延长和非计划就医)之间的关联:这是一项在儿童肿瘤学组(COG)国家癌症研究所社区肿瘤学研究计划(NCORP)机构进行的回顾性研究。符合条件的患者在 2014 年 1 月至 2015 年 12 月期间作为住院患者接受了高度(HEC)或中度致吐化疗(MEC),并且之前已加入 COG 研究。COG生成一份患者名单,参与研究的研究机构从中随机抽取患者进行病历审查。由一个中央小组裁定所接受的 CIV 预防治疗是否符合 CPG:结果:24 个研究机构参与了这项研究。超过一半的患者接受了与 CPG 不一致的 CIV 预防治疗(HEC:59/112,52.6%;MEC:119/215,55.3%)。CPG不一致的最常见原因是止吐药用药时间缩短或漏用地塞米松。研究发现,医疗机构的规模与不符合 CPG 的护理方法无关(HEC:调整后的几率比 [OR]:0.96,95% 置信区间:0.96,95% 置信区间 [CI]:0.96,95% 置信区间 [CI]:0.76-1.23;MEC:调整后 OR:1.07;95% CI:0.92-1.24)。此外,接受与 CPG 不一致的护理与患者预后之间没有统计学意义:结论:接受MEC或HEC治疗的患者通常会接受与CPG不一致的CIV预防治疗。手术部位的大小与接受不符合 CPG 的护理无关。未来的研究应评估改善儿科肿瘤患者CIV控制的策略,包括旨在改善CPG依从性的策略。
{"title":"Clinical practice guideline-inconsistent chemotherapy-induced vomiting prophylaxis in pediatric cancer patients in community settings: A Children's Oncology Group study","authors":"Aaron J. Sugalski,&nbsp;Allison C. Grimes,&nbsp;Michelle M. Nuño,&nbsp;Subhash Ramakrishnan,&nbsp;Melissa P. Beauchemin,&nbsp;Paula D. Robinson,&nbsp;Nancy Santesso,&nbsp;Alexandra M. Walsh,&nbsp;Andrea R. Wrightson,&nbsp;Lolie C. Yu,&nbsp;Susan K. Parsons,&nbsp;Lillian Sung,&nbsp;L. Lee Dupuis","doi":"10.1002/pbc.31295","DOIUrl":"10.1002/pbc.31295","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>This study aimed to determine the proportion of patients receiving clinical practice guideline (CPG)-inconsistent care related to chemotherapy-induced vomiting (CIV) prophylaxis, and to describe the association between CPG-inconsistent care and site size. The association between delivery of CPG-inconsistent care and patient outcomes (CIV control, admission prolongation, and unplanned healthcare visits) was also described.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This was a retrospective study conducted at Children's Oncology Group (COG) National Cancer Institute Community Oncology Research Program (NCORP) sites. Eligible patients received highly (HEC) or moderately emetogenic chemotherapy (MEC) as inpatients from January 2014 through December 2015, and were previously enrolled in a COG study. The COG generated a patient list from which patients were randomly selected for chart review by participating sites. A central panel adjudicated CIV prophylaxis received as CPG-consistent or -inconsistent.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Twenty-four sites participated. Over half of patients received CPG-inconsistent CIV prophylaxis (HEC: 59/112, 52.6%; MEC: 119/215, 55.3%). The most common reasons for CPG-inconsistency were shortened duration of antiemetic administration or omission of dexamethasone. Site size was not found to be associated with CPG-inconsistent care delivery (HEC: adjusted odds ratio [OR]: 0.96, 95% confidence interval [CI]: 0.76–1.23; MEC: adjusted OR: 1.07; 95% CI: 0.92–1.24). Additionally, there was no statistically significant association between receipt of CPG-inconsistent care and patient outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Patients receiving MEC or HEC often received CPG-inconsistent CIV prophylaxis. Site size was not associated with receipt of CPG-inconsistent care. Future studies should evaluate strategies to improve CIV control among pediatric oncology patients including those aimed at improving CPG adherence.</p>\u0000 </section>\u0000 </div>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pbc.31295","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The socio-cultural contexts shaping health-seeking behaviours among community members regarding childhood cancer in Tanzania: A qualitative study 坦桑尼亚影响社区成员儿童癌症就医行为的社会文化背景:定性研究。
IF 2.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2024-09-05 DOI: 10.1002/pbc.31278
Erica Samson Sanga, Doris D. Mbata, Elizabeth Francis Msoka, Zaina Mchome, Francis P. Karia, Kathryn I. Pollak, Joanna M. Robles, Kristin Schroeder

Background

Timely diagnosis of childhood cancer, early hospital presentation and completion of treatment significantly improve outcomes. Unfortunately, in Tanzania, thousands of children die of cancer each year without ever being diagnosed or treated. To reduce childhood death from cancer, it is important to understand the social-cultural context, values and beliefs that influence healthcare-seeking behaviours among the Tanzanian community.

Methods

This was a cross-sectional qualitative study conducted in Mwanza, Kilimanjaro and Dar-es-Salaam regions between March and June 2021. We purposively selected community members aged ≥18 years from three rural and three urban settings to participate in seven focus group discussions (each with eight to 12 respondents). The participants were from communities without any affiliation to the treatment of children with cancer or treatment facilities. We transcribed, coded and analyzed data using a thematic-content approach with the support of NVIVO 12 software.

Results

Many had heard of breast or cervical cancer; however, most were unaware of childhood cancer. Adults believe that cancer in children is caused by witchcraft and cannot be cured by modern medicines available at hospitals. These beliefs lead parents to first seek care from traditional healers, which hence delay presentation to the hospital. Other community concerns included the cost of transportation, investigation-related costs, and the long duration of treatment. These have an influence on treatment adherence leading to seeking alternative treatment, such as spiritual or traditional treatment.

Conclusion

Low community awareness, late hospital presentation, and treatment abandonment remain a challenge in childhood cancer in most parts of Tanzania. Belief about childhood cancer being a result of witchcraft and superstition contributes to limited health-seeking behaviours. Cultural and contextually relevant awareness campaign interventions are needed to increase cancer knowledge in Tanzanian communities.

背景:儿童癌症的及时诊断、早期入院和完成治疗可显著提高治疗效果。遗憾的是,在坦桑尼亚,每年有数千名儿童未经诊断或治疗而死于癌症。为了减少儿童死于癌症,了解影响坦桑尼亚社区儿童就医行为的社会文化背景、价值观和信仰非常重要:这是一项横断面定性研究,于 2021 年 3 月至 6 月间在姆万扎、乞力马扎罗和达累斯萨拉姆地区进行。我们从三个农村地区和三个城市地区有目的性地挑选了年龄≥18 岁的社区成员,参加了七次焦点小组讨论(每次有 8 至 12 名受访者)。参与者来自与癌症儿童治疗或治疗机构没有任何关联的社区。在 NVIVO 12 软件的支持下,我们采用主题内容法对数据进行了转录、编码和分析:结果:许多人听说过乳腺癌或宫颈癌,但大多数人并不知道儿童癌症。成年人认为儿童癌症是由巫术引起的,医院里的现代药物无法治愈。这些观念导致家长首先向传统医士求医,从而延误了到医院就诊的时间。社区关注的其他问题还包括交通费用、与调查相关的费用以及漫长的治疗时间。这些都会影响治疗的依从性,从而导致寻求其他治疗方法,如精神治疗或传统治疗:结论:在坦桑尼亚的大部分地区,社区对儿童癌症的认知度低、住院时间晚以及放弃治疗仍然是儿童癌症面临的挑战。认为儿童癌症是巫术和迷信的结果导致了有限的求医行为。要提高坦桑尼亚社区对癌症的认识,需要采取与文化和背景相关的宣传活动干预措施。
{"title":"The socio-cultural contexts shaping health-seeking behaviours among community members regarding childhood cancer in Tanzania: A qualitative study","authors":"Erica Samson Sanga,&nbsp;Doris D. Mbata,&nbsp;Elizabeth Francis Msoka,&nbsp;Zaina Mchome,&nbsp;Francis P. Karia,&nbsp;Kathryn I. Pollak,&nbsp;Joanna M. Robles,&nbsp;Kristin Schroeder","doi":"10.1002/pbc.31278","DOIUrl":"10.1002/pbc.31278","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Timely diagnosis of childhood cancer, early hospital presentation and completion of treatment significantly improve outcomes. Unfortunately, in Tanzania, thousands of children die of cancer each year without ever being diagnosed or treated. To reduce childhood death from cancer, it is important to understand the social-cultural context, values and beliefs that influence healthcare-seeking behaviours among the Tanzanian community.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This was a cross-sectional qualitative study conducted in Mwanza, Kilimanjaro and Dar-es-Salaam regions between March and June 2021. We purposively selected community members aged ≥18 years from three rural and three urban settings to participate in seven focus group discussions (each with eight to 12 respondents). The participants were from communities without any affiliation to the treatment of children with cancer or treatment facilities. We transcribed, coded and analyzed data using a thematic-content approach with the support of NVIVO 12 software.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Many had heard of breast or cervical cancer; however, most were unaware of childhood cancer. Adults believe that cancer in children is caused by witchcraft and cannot be cured by modern medicines available at hospitals. These beliefs lead parents to first seek care from traditional healers, which hence delay presentation to the hospital. Other community concerns included the cost of transportation, investigation-related costs, and the long duration of treatment. These have an influence on treatment adherence leading to seeking alternative treatment, such as spiritual or traditional treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Low community awareness, late hospital presentation, and treatment abandonment remain a challenge in childhood cancer in most parts of Tanzania. Belief about childhood cancer being a result of witchcraft and superstition contributes to limited health-seeking behaviours. Cultural and contextually relevant awareness campaign interventions are needed to increase cancer knowledge in Tanzanian communities.</p>\u0000 </section>\u0000 </div>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incorporating innovative B-cell targeting therapeutics into a combined-modality bridging approach followed by timely consolidative haploidentical transplantation to salvage a pediatric patient with relapsed/refractory diffuse large B-cell lymphoma 将创新性B细胞靶向疗法纳入联合模式桥接方法,然后及时进行巩固性单倍体移植,挽救一名复发/难治性弥漫大B细胞淋巴瘤儿科患者。
IF 2.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2024-09-04 DOI: 10.1002/pbc.31289
Yu-Ju Chao, Pei-Ing Lee, Tzu-Hsien Yang, Li-Hua Fang, Yu-Chun Tsai, Ming-Yuan Lee, Yun-Hsin Wang, Liuh-Yow Chen, Rong-Long Chen
{"title":"Incorporating innovative B-cell targeting therapeutics into a combined-modality bridging approach followed by timely consolidative haploidentical transplantation to salvage a pediatric patient with relapsed/refractory diffuse large B-cell lymphoma","authors":"Yu-Ju Chao,&nbsp;Pei-Ing Lee,&nbsp;Tzu-Hsien Yang,&nbsp;Li-Hua Fang,&nbsp;Yu-Chun Tsai,&nbsp;Ming-Yuan Lee,&nbsp;Yun-Hsin Wang,&nbsp;Liuh-Yow Chen,&nbsp;Rong-Long Chen","doi":"10.1002/pbc.31289","DOIUrl":"10.1002/pbc.31289","url":null,"abstract":"","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A modern approach to multiple pulmonary resections in children with recurrent metastatic pulmonary disease 对复发性转移性肺部疾病患儿进行多次肺切除术的现代方法。
IF 2.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2024-09-03 DOI: 10.1002/pbc.31304
Nikhil R. Shah, Keyonna M. Williams, Tammy Stoll, Amer Heider, Valerie P. Opipari, Rama Jasty Rao, Erika A. Newman, Peter F. Ehrlich, James D. Geiger

Implications of repeated resections of pulmonary metastasis (PM) are not well documented in the modern era. Fifteen children underwent two (n = 8), three (n = 3), or four or more (n = 3) resections (total = 38 procedures), most commonly for osteosarcoma (71%). Operative approach included muscle-sparing thoracotomy (71%), non-muscle-sparing thoracotomy (18%), and video-assisted thoracoscopy (11%). Median resected nodules per procedure was four (range = 1–95). Prolonged air leaks were the most common postoperative complication (29%). Median hospital stay was 4 days, and no children were discharged with or have required oxygen. Event-free survival is 67% at median follow-up time of 54 months, with an overall survival rate of 64%. Repeat resection of PM appears to be well tolerated, without prolonged hospital stays or compromised pulmonary function.

在现代,反复切除肺转移瘤(PM)的影响并没有得到很好的记录。15名儿童接受了两次(8例)、三次(3例)或四次或四次以上(3例)切除术(共38例),最常见的是骨肉瘤(71%)。手术方法包括保肌开胸(71%)、非保肌开胸(18%)和视频辅助胸腔镜(11%)。每次手术切除结节的中位数为 4 个(范围 = 1-95)。长期漏气是最常见的术后并发症(29%)。住院时间中位数为 4 天,没有患儿出院时需要吸氧。中位随访时间为 54 个月,无事件生存率为 67%,总生存率为 64%。重复切除 PM 的耐受性良好,不会延长住院时间或损害肺功能。
{"title":"A modern approach to multiple pulmonary resections in children with recurrent metastatic pulmonary disease","authors":"Nikhil R. Shah,&nbsp;Keyonna M. Williams,&nbsp;Tammy Stoll,&nbsp;Amer Heider,&nbsp;Valerie P. Opipari,&nbsp;Rama Jasty Rao,&nbsp;Erika A. Newman,&nbsp;Peter F. Ehrlich,&nbsp;James D. Geiger","doi":"10.1002/pbc.31304","DOIUrl":"10.1002/pbc.31304","url":null,"abstract":"<p>Implications of repeated resections of pulmonary metastasis (PM) are not well documented in the modern era. Fifteen children underwent two (<i>n</i> = 8), three (<i>n</i> = 3), or four or more (<i>n</i> = 3) resections (total = 38 procedures), most commonly for osteosarcoma (71%). Operative approach included muscle-sparing thoracotomy (71%), non-muscle-sparing thoracotomy (18%), and video-assisted thoracoscopy (11%). Median resected nodules per procedure was four (range = 1–95). Prolonged air leaks were the most common postoperative complication (29%). Median hospital stay was 4 days, and no children were discharged with or have required oxygen. Event-free survival is 67% at median follow-up time of 54 months, with an overall survival rate of 64%. Repeat resection of PM appears to be well tolerated, without prolonged hospital stays or compromised pulmonary function.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pbc.31304","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome 患有 22q11.2 缺失综合征的儿童、青少年和成人的血小板变化和出血症状。
IF 2.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2024-09-03 DOI: 10.1002/pbc.31292
Atsushi Sakamoto, Toru Uchiyama, Ryohei Futatsugi, Osamu Ohara, Akihiro Iguchi, Tadashi Kaname, Makoto Hikosaka, Hiroshi Ono, Shinji Kunishima, Shuichi Ito, Akira Ishiguro

Background

The deletion region of 22q11.2 deletion syndrome (22q11.2DS) contains a gene encoding glycoprotein Ibβ (GPIbβ), which is required to express the GPIb/IX/V complex on the platelet surface. Therefore, patients with 22q11.2DS may have congenital platelet disorders. However, information is limited on platelets and bleeding symptoms. In this study, we investigated clinical information, including bleeding symptoms, platelet counts, and GPIb expression levels in children and adolescents/adults with 22q11.2DS.

Procedure

Thirty-two patients with 22q11.2DS were enrolled in a prospective cohort study between 2022 and 2023 at outpatient clinics within our institute.

Results

The median platelet counts in adolescents/adults with 22q11.2DS were significantly lower than those in children (< .0001). A gradual decrease was found along with increasing age (= .0006). Values of median GPIb expression on platelet surfaces (66% in children and 70% in adolescents/adults) were significantly lower than those in healthy controls (< .0001 and = .0002). Bleeding symptoms included surgery-related bleeding (52%), purpura (31%), and epistaxis (22%); most of them were minor. The median International Society on Thrombosis and Hemostasis bleeding assessment tool score was not significantly different between children and adolescents/adults (= .2311).

Conclusion

Although there was an age-related decrease in platelet count and a disease-related decrease in GPIb expression, no difference in bleeding symptoms was found between children and adolescents/adults. 22q11.2DS overall had minor bleeding symptoms in daily life, and the disease had little effect on spontaneous bleeding. However, some patients had major bleeding events; further accumulation of data on hemostasis during surgery and trauma is required.

背景:22q11.2 缺失综合征(22q11.2DS)的缺失区含有一个编码糖蛋白 Ibβ(GPIbβ)的基因,该基因是在血小板表面表达 GPIb/IX/V 复合物所必需的。因此,22q11.2DS 患者可能患有先天性血小板疾病。然而,有关血小板和出血症状的信息非常有限。在这项研究中,我们调查了 22q11.2DS 儿童和青少年/成人的临床信息,包括出血症状、血小板计数和 GPIb 表达水平:在 2022 年至 2023 年期间,本研究所门诊部招募了 32 名 22q11.2DS 患者进行前瞻性队列研究:结果:22q11.2DS 青少年/成人的血小板计数中位数明显低于儿童(p 结论:虽然血小板计数随年龄的增长而降低,但22q11.2DS 青少年/成人的血小板计数中位数明显低于儿童:虽然血小板计数的下降与年龄有关,GPIb表达的下降与疾病有关,但儿童和青少年/成人的出血症状没有差异。22q11.2DS患者在日常生活中的出血症状总体较轻,该疾病对自发性出血的影响很小。但也有一些患者发生了大出血;需要进一步积累手术和创伤时的止血数据。
{"title":"Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome","authors":"Atsushi Sakamoto,&nbsp;Toru Uchiyama,&nbsp;Ryohei Futatsugi,&nbsp;Osamu Ohara,&nbsp;Akihiro Iguchi,&nbsp;Tadashi Kaname,&nbsp;Makoto Hikosaka,&nbsp;Hiroshi Ono,&nbsp;Shinji Kunishima,&nbsp;Shuichi Ito,&nbsp;Akira Ishiguro","doi":"10.1002/pbc.31292","DOIUrl":"10.1002/pbc.31292","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The deletion region of 22q11.2 deletion syndrome (22q11.2DS) contains a gene encoding glycoprotein Ibβ (GPIbβ), which is required to express the GPIb/IX/V complex on the platelet surface. Therefore, patients with 22q11.2DS may have congenital platelet disorders. However, information is limited on platelets and bleeding symptoms. In this study, we investigated clinical information, including bleeding symptoms, platelet counts, and GPIb expression levels in children and adolescents/adults with 22q11.2DS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Procedure</h3>\u0000 \u0000 <p>Thirty-two patients with 22q11.2DS were enrolled in a prospective cohort study between 2022 and 2023 at outpatient clinics within our institute.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The median platelet counts in adolescents/adults with 22q11.2DS were significantly lower than those in children (<i>p </i>&lt; .0001). A gradual decrease was found along with increasing age (<i>p </i>= .0006). Values of median GPIb expression on platelet surfaces (66% in children and 70% in adolescents/adults) were significantly lower than those in healthy controls (<i>p </i>&lt; .0001 and <i>p </i>= .0002). Bleeding symptoms included surgery-related bleeding (52%), purpura (31%), and epistaxis (22%); most of them were minor. The median International Society on Thrombosis and Hemostasis bleeding assessment tool score was not significantly different between children and adolescents/adults (<i>p </i>= .2311).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Although there was an age-related decrease in platelet count and a disease-related decrease in GPIb expression, no difference in bleeding symptoms was found between children and adolescents/adults. 22q11.2DS overall had minor bleeding symptoms in daily life, and the disease had little effect on spontaneous bleeding. However, some patients had major bleeding events; further accumulation of data on hemostasis during surgery and trauma is required.</p>\u0000 </section>\u0000 </div>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parental smoking and respiratory outcomes in young childhood cancer survivors 父母吸烟与儿童癌症幸存者的呼吸系统后果
IF 2.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2024-09-03 DOI: 10.1002/pbc.31310
Maša Žarković, Grit Sommer, Carina Nigg, Tomáš Sláma, Christine Schneider, Marc Ansari, Nicolas von der Weid, Christina Schindera, Claudia E Kuehni

Background

Passive exposure to cigarette smoke has negative effects on respiratory health. Childhood cancer survivors (CCS) are at increased risk for respiratory disease due to treatment regimens that may harm the respiratory system. The objective of this study was to assess the prevalence of parental smoking among CCS and investigate its association with respiratory outcomes.

Procedure

As part of the Swiss Childhood Cancer Survivor Study, between 2007 and 2022, we sent questionnaires to parents of children aged ≤16 years who had survived ≥5 years after a cancer diagnosis. Parents reported on their children's respiratory outcomes including recurrent upper respiratory tract infections (otitis media and sinusitis), asthma, and lower respiratory symptoms (chronic cough persisting >3 months, current and exercise wheeze), and on parental smoking. We used multivariable logistic regression to investigate associations between parental smoking and respiratory outcomes.

Results

Our study included 1037 CCS (response rate 66%). Median age at study was 12 years (interquartile range 10–14 years). Eighteen percent of mothers and 23% of fathers reported current smoking. CCS exposed to smoking mothers were more likely to have recurrent upper respiratory tract infections (OR 2.1; 95%CI 1.1–3.7) and lower respiratory symptoms (OR 2.0; 95%CI 1.1–3.7). We found no association with paternal smoking.

Conclusions

A substantial proportion of CCS in Switzerland have parents who smoke. Exposure to maternal smoking was associated with higher prevalence of upper and lower respiratory problems. Healthcare providers can support families by addressing caregiver smoking behaviors and providing referrals to smoking cessation programs.

背景:被动接触香烟烟雾会对呼吸系统健康产生负面影响。儿童癌症幸存者(CCS)的治疗方案可能会损害呼吸系统,因此患呼吸系统疾病的风险增加。本研究的目的是评估父母在儿童癌症幸存者中的吸烟率,并调查其与呼吸系统结果的关系:作为瑞士儿童癌症幸存者研究(Swiss Childhood Cancer Survivor Study)的一部分,我们在 2007 年至 2022 年期间向癌症确诊后存活≥5 年、年龄≤16 岁儿童的父母发送了调查问卷。家长们报告了他们孩子的呼吸系统结果,包括复发性上呼吸道感染(中耳炎和鼻窦炎)、哮喘、下呼吸道症状(持续 3 个月以上的慢性咳嗽、当前和运动性喘息)以及家长吸烟情况。我们使用多变量逻辑回归法研究了父母吸烟与呼吸系统结果之间的关系:我们的研究包括 1037 名儿童和青少年(回复率为 66%)。研究时的年龄中位数为 12 岁(四分位数间距为 10-14 岁)。18%的母亲和23%的父亲表示目前正在吸烟。母亲吸烟的儿童更容易反复出现上呼吸道感染(OR 2.1; 95%CI 1.1-3.7)和下呼吸道症状(OR 2.0; 95%CI 1.1-3.7)。我们没有发现这与父亲吸烟有关:结论:在瑞士,父母吸烟的儿童占儿童总数的很大比例。结论:在瑞士,有相当一部分儿童的父母吸烟。母亲吸烟与较高的上下呼吸道疾病发病率有关。医疗服务提供者可以通过解决照顾者的吸烟行为和提供戒烟计划转介来为家庭提供支持。
{"title":"Parental smoking and respiratory outcomes in young childhood cancer survivors","authors":"Maša Žarković,&nbsp;Grit Sommer,&nbsp;Carina Nigg,&nbsp;Tomáš Sláma,&nbsp;Christine Schneider,&nbsp;Marc Ansari,&nbsp;Nicolas von der Weid,&nbsp;Christina Schindera,&nbsp;Claudia E Kuehni","doi":"10.1002/pbc.31310","DOIUrl":"10.1002/pbc.31310","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Passive exposure to cigarette smoke has negative effects on respiratory health. Childhood cancer survivors (CCS) are at increased risk for respiratory disease due to treatment regimens that may harm the respiratory system. The objective of this study was to assess the prevalence of parental smoking among CCS and investigate its association with respiratory outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Procedure</h3>\u0000 \u0000 <p>As part of the Swiss Childhood Cancer Survivor Study, between 2007 and 2022, we sent questionnaires to parents of children aged ≤16 years who had survived ≥5 years after a cancer diagnosis. Parents reported on their children's respiratory outcomes including recurrent upper respiratory tract infections (otitis media and sinusitis), asthma, and lower respiratory symptoms (chronic cough persisting &gt;3 months, current and exercise wheeze), and on parental smoking. We used multivariable logistic regression to investigate associations between parental smoking and respiratory outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Our study included 1037 CCS (response rate 66%). Median age at study was 12 years (interquartile range 10–14 years). Eighteen percent of mothers and 23% of fathers reported current smoking. CCS exposed to smoking mothers were more likely to have recurrent upper respiratory tract infections (OR 2.1; 95%CI 1.1–3.7) and lower respiratory symptoms (OR 2.0; 95%CI 1.1–3.7). We found no association with paternal smoking.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>A substantial proportion of CCS in Switzerland have parents who smoke. Exposure to maternal smoking was associated with higher prevalence of upper and lower respiratory problems. Healthcare providers can support families by addressing caregiver smoking behaviors and providing referrals to smoking cessation programs.</p>\u0000 </section>\u0000 </div>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pbc.31310","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Cost-effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India. 评论:北印度一家三级医疗中心治疗儿童急性髓性白血病的成本效益。
IF 2.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2024-09-03 DOI: 10.1002/pbc.31305
Manraj Singh Sra, Sameer Bakhshi, Shuvadeep Ganguly
{"title":"Comment on: Cost-effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India.","authors":"Manraj Singh Sra, Sameer Bakhshi, Shuvadeep Ganguly","doi":"10.1002/pbc.31305","DOIUrl":"https://doi.org/10.1002/pbc.31305","url":null,"abstract":"","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Incorporation of patient-reported outcomes in early-phase clinical trials for childhood and adolescent cancer 评论:在儿童和青少年癌症早期临床试验中纳入患者报告结果。
IF 2.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2024-09-03 DOI: 10.1002/pbc.31306
Gabriel Revon-Riviere, Denise Connolly, Sarah Cohen-Gogo
{"title":"Comment on: Incorporation of patient-reported outcomes in early-phase clinical trials for childhood and adolescent cancer","authors":"Gabriel Revon-Riviere,&nbsp;Denise Connolly,&nbsp;Sarah Cohen-Gogo","doi":"10.1002/pbc.31306","DOIUrl":"10.1002/pbc.31306","url":null,"abstract":"","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of fulminant botulism after allogeneic hematopoietic cell transplantation 异体造血细胞移植后暴发性肉毒中毒的处理。
IF 2.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2024-09-03 DOI: 10.1002/pbc.31309
Nao Takasugi, Kaname Uchida, Konomi Shimoda, Eiichiro Watanabe, Shota Kato, Mitsuteru Hiwatari, Mahoko Ikeda, Motohiro Kato, Hikoro Matsui
{"title":"Management of fulminant botulism after allogeneic hematopoietic cell transplantation","authors":"Nao Takasugi,&nbsp;Kaname Uchida,&nbsp;Konomi Shimoda,&nbsp;Eiichiro Watanabe,&nbsp;Shota Kato,&nbsp;Mitsuteru Hiwatari,&nbsp;Mahoko Ikeda,&nbsp;Motohiro Kato,&nbsp;Hikoro Matsui","doi":"10.1002/pbc.31309","DOIUrl":"10.1002/pbc.31309","url":null,"abstract":"","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee 会阴和肛周横纹肌肉瘤患者的预后:儿童肿瘤组织软组织肉瘤委员会的报告。
IF 2.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2024-09-03 DOI: 10.1002/pbc.31303
Roshni Dasgupta, Wei Xue, Andrea Hayes Dixon, Suzanne Wolden, Torunn I. Yock, Rajkumar Venkatramani, David A. Rodeberg

Purpose

To describe clinical features, risk factors, and outcomes of patients with perineal and perianal rhabdomyosarcoma.

Methods

The records of 51 patients (38 perineal and 13 perianal) enrolled on Children's Oncology Group clinical trials between 1997 and 2012 were reviewed.

Results

At presentation, 53% were female, 65% were older than 10 years of age, 76% were alveolar histology, 76% were more than 5 cm, 84% were invasive, 65% were regional node positive by imaging, 49% were metastatic, only 16% were grossly resected upfront, and 25% of patients had a delayed excision. At a median follow-up of 6.13 years, estimated 5-year event-free survival (EFS) was 38% [22.17%–53.38%], and overall survival (OS) was 42% [26.66%–58.21%]. The rates of local, regional, and distant failure were 15.6%, 13.7%, 43.1%, respectively; all failures ultimately died. By univariate analysis, only age more than 10 years negatively impacted 5-year EFS (p = .023) and OS (p = .09), and IRS Group also impacted OS (p = .043). In Cox proportional hazards model, neither of these variables were significant after adjusting for other factors.

Conclusion

Patients with perineal and perianal rhabdomyosarcoma have a poor overall prognosis, probably related to poor patient and disease characteristics at presentation.

目的:描述会阴和肛周横纹肌肉瘤患者的临床特征、风险因素和预后:方法:回顾性分析1997年至2012年间参加儿童肿瘤集团临床试验的51名患者(38名会阴部和13名肛周)的病历:发病时,53%为女性,65%年龄大于10岁,76%为肺泡组织学,76%超过5厘米,84%为浸润性,65%影像学显示区域结节阳性,49%为转移性,仅16%在前期进行了大体切除,25%的患者进行了延迟切除。中位随访时间为6.13年,估计5年无事件生存率(EFS)为38% [22.17%-53.38%],总生存率(OS)为42% [26.66%-58.21%]。局部、区域和远处失败率分别为15.6%、13.7%和43.1%;所有失败者最终均死亡。通过单变量分析,只有年龄超过10岁才会对5年EFS(p = .023)和OS(p = .09)产生负面影响,IRS组也会影响OS(p = .043)。在Cox比例危险模型中,在调整了其他因素后,这两个变量均不显著:结论:会阴和肛周横纹肌肉瘤患者的总体预后较差,这可能与患者发病时的不良特征和疾病特征有关。
{"title":"Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee","authors":"Roshni Dasgupta,&nbsp;Wei Xue,&nbsp;Andrea Hayes Dixon,&nbsp;Suzanne Wolden,&nbsp;Torunn I. Yock,&nbsp;Rajkumar Venkatramani,&nbsp;David A. Rodeberg","doi":"10.1002/pbc.31303","DOIUrl":"10.1002/pbc.31303","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>To describe clinical features, risk factors, and outcomes of patients with perineal and perianal rhabdomyosarcoma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The records of 51 patients (38 perineal and 13 perianal) enrolled on Children's Oncology Group clinical trials between 1997 and 2012 were reviewed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>At presentation, 53% were female, 65% were older than 10 years of age, 76% were alveolar histology, 76% were more than 5 cm, 84% were invasive, 65% were regional node positive by imaging, 49% were metastatic, only 16% were grossly resected upfront, and 25% of patients had a delayed excision. At a median follow-up of 6.13 years, estimated 5-year event-free survival (EFS) was 38% [22.17%–53.38%], and overall survival (OS) was 42% [26.66%–58.21%]. The rates of local, regional, and distant failure were 15.6%, 13.7%, 43.1%, respectively; all failures ultimately died. By univariate analysis, only age more than 10 years negatively impacted 5-year EFS (<i>p</i> = .023) and OS (<i>p</i> = .09), and IRS Group also impacted OS (<i>p</i> = .043). In Cox proportional hazards model, neither of these variables were significant after adjusting for other factors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Patients with perineal and perianal rhabdomyosarcoma have a poor overall prognosis, probably related to poor patient and disease characteristics at presentation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric Blood & Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1